Human Liver Model Market to Grow with a CAGR of 4.12% through 2030
Pharmaceutical Research Advancements and Rising Incidence of Liver Diseases are expected to drive the Global Human Liver Model Market growth in the forecast period, 2026-2030
According to TechSci Research report, “Human Liver
Model Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2030F”, the Global Human Liver Model Market stood at
USD 615.95 Million in 2024 and is anticipated to grow with a CAGR of 4.12% in
the forecast period, 2026-2030.
The growth of the Global Human Liver Model Market is being significantly driven by industry collaborations and strategic partnerships. Academic institutions, pharmaceutical companies, and biotech firms are joining forces to accelerate the development and adoption of advanced liver models. These partnerships leverage complementary expertise and resources, facilitating faster innovation and commercialization of cutting-edge liver models for drug discovery and disease research.
Additionally, ethical concerns and the push for more humane research practices are driving a shift away from animal testing. Human liver models provide a viable alternative, offering human-specific data without the ethical and scientific limitations of animal-based research. As global regulatory bodies and research institutions continue to prioritize non-animal testing methods, adoption of human liver models is expected to rise significantly. Increasing investment in healthcare R&D, particularly in drug toxicity testing and liver disease research. Advancements in organ printing and bioengineering technologies, enhancing the accuracy and scalability of lab-grown liver models. Rising incidence of liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disorders, fueling demand for better diagnostic and therapeutic models. Growing emphasis on replacing animal-based models with human-relevant alternatives for more precise and predictive research outcomes.
However, challenges such as the high cost of developing liver models and complexities in integrating these models into existing pharmaceutical workflows may hinder market growth in the near term. Despite these barriers, continued technological advancements and regulatory support are expected to sustain the market’s upward trajectory.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Human Liver Model Market”
The Global Human Liver Model Market is segmented into product,
application, regional distribution, and company
Based on application, Drug discovery was poised to
continue dominating the Global Human Liver Model Market for several compelling
reasons. First and foremost, the pharmaceutical industry's unceasing quest for
innovative and effective therapies drives a constant demand for reliable liver
models to assess drug candidates. Human liver models play an irreplaceable role
in early-stage drug testing, enabling researchers to evaluate drug metabolism,
toxicity, and efficacy accurately. Moreover, the increasing complexity of drug
targets and the push towards personalized medicine necessitate more
sophisticated liver models, positioning drug discovery as a key driver of
innovation in this market. With ongoing advancements in tissue engineering and
biotechnology, drug discovery will likely maintain its dominance in the coming
years, ensuring that the Global Human Liver Model Market continues to thrive.
Based on region, Europe is positioned to experience the fastest growth in the Global Human Liver Model Market, driven by strong government support for biomedical research, increasing regulatory pressure to reduce animal testing, and advancements in biotechnology and organoid development. The European Union’s stringent regulations on animal testing, including the REACH regulation and the European Medicines Agency’s (EMA) initiatives, are accelerating the adoption of human-relevant liver models for drug discovery and toxicity testing. Additionally, the region boasts a highly developed pharmaceutical and biotech sector, with key players and research institutions actively investing in 3D bioprinting, liver-on-a-chip technologies, and stem cell-based liver models. Countries like Germany, the UK, and France are at the forefront of organ-on-a-chip and microfluidic liver model innovations, benefiting from robust funding from both public and private sectors. The UK’s emphasis on precision medicine and regenerative therapies, coupled with Germany’s leadership in bioengineering, further strengthens Europe’s position in this market. Additionally, the rising prevalence of liver diseases, including non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD), is driving the demand for more advanced and predictive human liver models.
Major companies operating in Global Human Liver
Model Market are:
- Organovo Holdings Inc
- BioIVT LLC
- InSphero AG
- Emulate Inc
- Mimetas BV
- CN Bio
- Cyfuse Biomedical KK
- Hurel Corp
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The Global Human Liver Model Market is on the cusp of
significant transformation, driven by emerging trends that promise to reshape
the landscape of pharmaceutical research and drug development. Integration of
AI, multi-organ-on-a-chip systems, patient-derived models, advanced tissue
engineering, microfluidic devices, collaborative research initiatives, and
regulatory acceptance are poised to revolutionize the industry,” said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Human Liver Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (2D Models, 3D Bio Printing, Liver Organoids), By Application (Drug Discovery, Academics & Research), By Region & Competition, 2020-2030F”, has evaluated
the future growth potential of Global Human Liver Model Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Human Liver Model Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com